NCT07532590 · RECRUITING
Patients With Pancreatic Tumor: Use of an App to Monitor Progress in a Simple and Intuitive Way by Periodically Completing Targeted Questionnaires and Providing Educational and Informational Content (PancreasPlus).
This study tests whether a smartphone app called PancreasPlus is practical and useful for people with pancreatic cancer. The app offers symptom tracking, questionnaires, and educational content. Researchers measure how often patients use it and how satisfied they are over 3 months. It is a study of usability, not a medical treatment, and has no formal phase.
You may qualify if
- Age ≥18; diagnosis of pancreatic cancer (histological/cytological)
- Access to a smartphone or tablet and a data connection; basic digital literacy or a caregiver available,
- Ability to understand and provide informed consent; understanding of the Italian language.
You're excluded if
- Severe uncompensated cognitive impairment,
- Social or logistical circumstances that prevent follow-up or access to/use of the app,
- Refusal or withdrawal of consent.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-05-11